GenAI is changing pharma operations. Explore real-world tools and use cases for AI in pharmaceutical industry workflows.

Sanofi announced it is punting more than $9 billion to acquire Blueprint Medicines and its Ayvakit, BLU-808 and immunology ...

Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry (ABPI) calling up its members to speak on the record, ...

The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...

In comments posted in response to the Trump administration’s pharma tariff investigation, companies and industry groups ...

Detailed price information for Quest Pharmatech Inc (QPT-X) from The Globe and Mail including charting and trades.

BTIG analysts upgraded Doximity, Inc. (NYSE:DOCS)’s stock from “Neutral” to “Buy” with the price objective of $80. The ...

In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...